Your browser doesn't support javascript.
Time Between Viral Loads for People With HIV During the COVID-19 Pandemic.
El-Nahal, Walid G; Shen, Nicola M; Keruly, Jeanne C; Jones, Joyce L; Fojo, Anthony T; Manabe, Yukari C; Moore, Richard D; Gebo, Kelly A; Chander, Geetanjali; Lesko, Catherine R.
  • El-Nahal WG; Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD; and.
  • Shen NM; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
  • Keruly JC; Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD; and.
  • Jones JL; Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD; and.
  • Fojo AT; Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD; and.
  • Manabe YC; Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD; and.
  • Moore RD; Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD; and.
  • Gebo KA; Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD; and.
  • Chander G; Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD; and.
  • Lesko CR; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
J Acquir Immune Defic Syndr ; 91(1): 109-116, 2022 09 01.
Article in English | MEDLINE | ID: covidwho-1992439
ABSTRACT

BACKGROUND:

During the COVID-19 pandemic, patients experienced significant care disruptions, including laboratory monitoring. We investigated changes in the time between viral load (VL) checks for people with HIV (PWH) associated with the pandemic. SETTING AND

METHODS:

This was an observational analysis of VLs of PWH in routine care at a large subspecialty clinic. At pandemic onset, the clinic temporarily closed its onsite laboratory. The exposure was time period (time varying) prepandemic (January 1, 2019-March 15, 2020); pandemic laboratory closed (March 16-July 12, 2020); and pandemic laboratory open (July 13-December 31, 2020). We estimated time from an index VL to a subsequent VL, stratified by whether the index VL was suppressed (≤200 copies/mL). We also calculated cumulative incidence of a nonsuppressed VL following a suppressed index VL, and of resuppression following a loss of viral suppression.

RESULTS:

Compared with prepandemic, hazard ratios for next VL check were 0.34 (95% CI 0.30 to 0.37, laboratory-closed) and 0.73 (CI 0.68 to 0.78, laboratory-open) for suppressed patients, and 0.56 (CI 0.42 to 0.79, laboratory-closed) and 0.92 (95% CI 0.76 to 1.10, laboratory-open) for nonsuppressed patients. The 12-month cumulative incidence of loss of suppression was the same in the pandemic laboratory-open (4%) and prepandemic (4%) period. The hazard of resuppression following the loss of suppression was lower during the pandemic laboratory-open versus the prepandemic period (hazard ratio 0.68, 95% CI 0.50 to 0.92).

CONCLUSIONS:

Early pandemic restrictions and laboratory closure significantly delayed VL monitoring. Once the laboratory reopened, nonsuppressed patients resumed normal monitoring. Suppressed patients still had a delay but no significant loss of suppression.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents / COVID-19 Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: J Acquir Immune Defic Syndr Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents / COVID-19 Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: J Acquir Immune Defic Syndr Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2022 Document Type: Article